Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Imatinib Mesylate Tablets Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 100 mg
1.2.3 400 mg
1.3 Market by Application
1.3.1 Global Imatinib Mesylate Tablets Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospital
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Imatinib Mesylate Tablets Market Perspective (2018-2034)
2.2 Imatinib Mesylate Tablets Growth Trends by Region
2.2.1 Global Imatinib Mesylate Tablets Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Imatinib Mesylate Tablets Historic Market Size by Region (2018-2023)
2.2.3 Imatinib Mesylate Tablets Forecasted Market Size by Region (2024-2034)
2.3 Imatinib Mesylate Tablets Market Dynamics
2.3.1 Imatinib Mesylate Tablets Industry Trends
2.3.2 Imatinib Mesylate Tablets Market Drivers
2.3.3 Imatinib Mesylate Tablets Market Challenges
2.3.4 Imatinib Mesylate Tablets Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Imatinib Mesylate Tablets Players by Revenue
3.1.1 Global Top Imatinib Mesylate Tablets Players by Revenue (2018-2023)
3.1.2 Global Imatinib Mesylate Tablets Revenue Market Share by Players (2018-2023)
3.2 Global Imatinib Mesylate Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Imatinib Mesylate Tablets Revenue
3.4 Global Imatinib Mesylate Tablets Market Concentration Ratio
3.4.1 Global Imatinib Mesylate Tablets Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Imatinib Mesylate Tablets Revenue in 2024
3.5 Imatinib Mesylate Tablets Key Players Head office and Area Served
3.6 Key Players Imatinib Mesylate Tablets Product Solution and Service
3.7 Date of Enter into Imatinib Mesylate Tablets Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Imatinib Mesylate Tablets Breakdown Data by Type
4.1 Global Imatinib Mesylate Tablets Historic Market Size by Type (2018-2023)
4.2 Global Imatinib Mesylate Tablets Forecasted Market Size by Type (2024-2034)
5 Imatinib Mesylate Tablets Breakdown Data by Application
5.1 Global Imatinib Mesylate Tablets Historic Market Size by Application (2018-2023)
5.2 Global Imatinib Mesylate Tablets Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Imatinib Mesylate Tablets Market Size (2018-2034)
6.2 North America Imatinib Mesylate Tablets Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Imatinib Mesylate Tablets Market Size by Country (2018-2023)
6.4 North America Imatinib Mesylate Tablets Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Imatinib Mesylate Tablets Market Size (2018-2034)
7.2 Europe Imatinib Mesylate Tablets Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Imatinib Mesylate Tablets Market Size by Country (2018-2023)
7.4 Europe Imatinib Mesylate Tablets Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Imatinib Mesylate Tablets Market Size (2018-2034)
8.2 Asia-Pacific Imatinib Mesylate Tablets Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Imatinib Mesylate Tablets Market Size by Region (2018-2023)
8.4 Asia-Pacific Imatinib Mesylate Tablets Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Imatinib Mesylate Tablets Market Size (2018-2034)
9.2 Latin America Imatinib Mesylate Tablets Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Imatinib Mesylate Tablets Market Size by Country (2018-2023)
9.4 Latin America Imatinib Mesylate Tablets Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Imatinib Mesylate Tablets Market Size (2018-2034)
10.2 Middle East & Africa Imatinib Mesylate Tablets Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Imatinib Mesylate Tablets Market Size by Country (2018-2023)
10.4 Middle East & Africa Imatinib Mesylate Tablets Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Teva Pharmaceuticals
11.1.1 Teva Pharmaceuticals Company Detail
11.1.2 Teva Pharmaceuticals Business Overview
11.1.3 Teva Pharmaceuticals Imatinib Mesylate Tablets Introduction
11.1.4 Teva Pharmaceuticals Revenue in Imatinib Mesylate Tablets Business (2018-2023)
11.1.5 Teva Pharmaceuticals Recent Development
11.2 Hikma Pharmaceuticals
11.2.1 Hikma Pharmaceuticals Company Detail
11.2.2 Hikma Pharmaceuticals Business Overview
11.2.3 Hikma Pharmaceuticals Imatinib Mesylate Tablets Introduction
11.2.4 Hikma Pharmaceuticals Revenue in Imatinib Mesylate Tablets Business (2018-2023)
11.2.5 Hikma Pharmaceuticals Recent Development
11.3 Apotex Inc
11.3.1 Apotex Inc Company Detail
11.3.2 Apotex Inc Business Overview
11.3.3 Apotex Inc Imatinib Mesylate Tablets Introduction
11.3.4 Apotex Inc Revenue in Imatinib Mesylate Tablets Business (2018-2023)
11.3.5 Apotex Inc Recent Development
11.4 Sun Pharmaceutical Industries
11.4.1 Sun Pharmaceutical Industries Company Detail
11.4.2 Sun Pharmaceutical Industries Business Overview
11.4.3 Sun Pharmaceutical Industries Imatinib Mesylate Tablets Introduction
11.4.4 Sun Pharmaceutical Industries Revenue in Imatinib Mesylate Tablets Business (2018-2023)
11.4.5 Sun Pharmaceutical Industries Recent Development
11.5 Lupin Limited
11.5.1 Lupin Limited Company Detail
11.5.2 Lupin Limited Business Overview
11.5.3 Lupin Limited Imatinib Mesylate Tablets Introduction
11.5.4 Lupin Limited Revenue in Imatinib Mesylate Tablets Business (2018-2023)
11.5.5 Lupin Limited Recent Development
11.6 Natco Pharma
11.6.1 Natco Pharma Company Detail
11.6.2 Natco Pharma Business Overview
11.6.3 Natco Pharma Imatinib Mesylate Tablets Introduction
11.6.4 Natco Pharma Revenue in Imatinib Mesylate Tablets Business (2018-2023)
11.6.5 Natco Pharma Recent Development
11.7 Getwell Oncology
11.7.1 Getwell Oncology Company Detail
11.7.2 Getwell Oncology Business Overview
11.7.3 Getwell Oncology Imatinib Mesylate Tablets Introduction
11.7.4 Getwell Oncology Revenue in Imatinib Mesylate Tablets Business (2018-2023)
11.7.5 Getwell Oncology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Imatinib Mesylate Tablets Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of 100 mg
Table 3. Key Players of 400 mg
Table 4. Global Imatinib Mesylate Tablets Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global Imatinib Mesylate Tablets Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Imatinib Mesylate Tablets Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Imatinib Mesylate Tablets Market Share by Region (2018-2023)
Table 8. Global Imatinib Mesylate Tablets Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global Imatinib Mesylate Tablets Market Share by Region (2024-2034)
Table 10. Imatinib Mesylate Tablets Market Trends
Table 11. Imatinib Mesylate Tablets Market Drivers
Table 12. Imatinib Mesylate Tablets Market Challenges
Table 13. Imatinib Mesylate Tablets Market Restraints
Table 14. Global Imatinib Mesylate Tablets Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Imatinib Mesylate Tablets Market Share by Players (2018-2023)
Table 16. Global Top Imatinib Mesylate Tablets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Mesylate Tablets as of 2024)
Table 17. Ranking of Global Top Imatinib Mesylate Tablets Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Imatinib Mesylate Tablets Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Imatinib Mesylate Tablets Product Solution and Service
Table 21. Date of Enter into Imatinib Mesylate Tablets Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Imatinib Mesylate Tablets Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Imatinib Mesylate Tablets Revenue Market Share by Type (2018-2023)
Table 25. Global Imatinib Mesylate Tablets Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global Imatinib Mesylate Tablets Revenue Market Share by Type (2024-2034)
Table 27. Global Imatinib Mesylate Tablets Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Imatinib Mesylate Tablets Revenue Market Share by Application (2018-2023)
Table 29. Global Imatinib Mesylate Tablets Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global Imatinib Mesylate Tablets Revenue Market Share by Application (2024-2034)
Table 31. North America Imatinib Mesylate Tablets Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America Imatinib Mesylate Tablets Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Imatinib Mesylate Tablets Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe Imatinib Mesylate Tablets Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe Imatinib Mesylate Tablets Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Imatinib Mesylate Tablets Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific Imatinib Mesylate Tablets Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific Imatinib Mesylate Tablets Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Imatinib Mesylate Tablets Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America Imatinib Mesylate Tablets Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America Imatinib Mesylate Tablets Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Imatinib Mesylate Tablets Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa Imatinib Mesylate Tablets Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa Imatinib Mesylate Tablets Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Imatinib Mesylate Tablets Market Size by Country (2024-2034) & (US$ Million)
Table 46. Teva Pharmaceuticals Company Detail
Table 47. Teva Pharmaceuticals Business Overview
Table 48. Teva Pharmaceuticals Imatinib Mesylate Tablets Product
Table 49. Teva Pharmaceuticals Revenue in Imatinib Mesylate Tablets Business (2018-2023) & (US$ Million)
Table 50. Teva Pharmaceuticals Recent Development
Table 51. Hikma Pharmaceuticals Company Detail
Table 52. Hikma Pharmaceuticals Business Overview
Table 53. Hikma Pharmaceuticals Imatinib Mesylate Tablets Product
Table 54. Hikma Pharmaceuticals Revenue in Imatinib Mesylate Tablets Business (2018-2023) & (US$ Million)
Table 55. Hikma Pharmaceuticals Recent Development
Table 56. Apotex Inc Company Detail
Table 57. Apotex Inc Business Overview
Table 58. Apotex Inc Imatinib Mesylate Tablets Product
Table 59. Apotex Inc Revenue in Imatinib Mesylate Tablets Business (2018-2023) & (US$ Million)
Table 60. Apotex Inc Recent Development
Table 61. Sun Pharmaceutical Industries Company Detail
Table 62. Sun Pharmaceutical Industries Business Overview
Table 63. Sun Pharmaceutical Industries Imatinib Mesylate Tablets Product
Table 64. Sun Pharmaceutical Industries Revenue in Imatinib Mesylate Tablets Business (2018-2023) & (US$ Million)
Table 65. Sun Pharmaceutical Industries Recent Development
Table 66. Lupin Limited Company Detail
Table 67. Lupin Limited Business Overview
Table 68. Lupin Limited Imatinib Mesylate Tablets Product
Table 69. Lupin Limited Revenue in Imatinib Mesylate Tablets Business (2018-2023) & (US$ Million)
Table 70. Lupin Limited Recent Development
Table 71. Natco Pharma Company Detail
Table 72. Natco Pharma Business Overview
Table 73. Natco Pharma Imatinib Mesylate Tablets Product
Table 74. Natco Pharma Revenue in Imatinib Mesylate Tablets Business (2018-2023) & (US$ Million)
Table 75. Natco Pharma Recent Development
Table 76. Getwell Oncology Company Detail
Table 77. Getwell Oncology Business Overview
Table 78. Getwell Oncology Imatinib Mesylate Tablets Product
Table 79. Getwell Oncology Revenue in Imatinib Mesylate Tablets Business (2018-2023) & (US$ Million)
Table 80. Getwell Oncology Recent Development
Table 81. Research Programs/Design for This Report
Table 82. Key Data Information from Secondary Sources
Table 83. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Imatinib Mesylate Tablets Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Imatinib Mesylate Tablets Market Share by Type: 2024 VS 2034
Figure 3. 100 mg Features
Figure 4. 400 mg Features
Figure 5. Global Imatinib Mesylate Tablets Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Imatinib Mesylate Tablets Market Share by Application: 2024 VS 2034
Figure 7. Hospital Case Studies
Figure 8. Clinics Case Studies
Figure 9. Imatinib Mesylate Tablets Report Years Considered
Figure 10. Global Imatinib Mesylate Tablets Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 11. Global Imatinib Mesylate Tablets Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Imatinib Mesylate Tablets Market Share by Region: 2024 VS 2034
Figure 13. Global Imatinib Mesylate Tablets Market Share by Players in 2024
Figure 14. Global Top Imatinib Mesylate Tablets Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Imatinib Mesylate Tablets as of 2024)
Figure 15. The Top 10 and 5 Players Market Share by Imatinib Mesylate Tablets Revenue in 2024
Figure 16. North America Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 17. North America Imatinib Mesylate Tablets Market Share by Country (2018-2034)
Figure 18. United States Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. Canada Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Europe Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe Imatinib Mesylate Tablets Market Share by Country (2018-2034)
Figure 22. Germany Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. France Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. U.K. Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Italy Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Russia Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Nordic Countries Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Asia-Pacific Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific Imatinib Mesylate Tablets Market Share by Region (2018-2034)
Figure 30. China Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Japan Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. South Korea Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Southeast Asia Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. India Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Australia Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Latin America Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America Imatinib Mesylate Tablets Market Share by Country (2018-2034)
Figure 38. Mexico Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Brazil Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Middle East & Africa Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa Imatinib Mesylate Tablets Market Share by Country (2018-2034)
Figure 42. Turkey Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Saudi Arabia Imatinib Mesylate Tablets Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Teva Pharmaceuticals Revenue Growth Rate in Imatinib Mesylate Tablets Business (2018-2023)
Figure 45. Hikma Pharmaceuticals Revenue Growth Rate in Imatinib Mesylate Tablets Business (2018-2023)
Figure 46. Apotex Inc Revenue Growth Rate in Imatinib Mesylate Tablets Business (2018-2023)
Figure 47. Sun Pharmaceutical Industries Revenue Growth Rate in Imatinib Mesylate Tablets Business (2018-2023)
Figure 48. Lupin Limited Revenue Growth Rate in Imatinib Mesylate Tablets Business (2018-2023)
Figure 49. Natco Pharma Revenue Growth Rate in Imatinib Mesylate Tablets Business (2018-2023)
Figure 50. Getwell Oncology Revenue Growth Rate in Imatinib Mesylate Tablets Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed